• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脂质辅料在测试制剂的SLN生产中的化学稳定性、表征及短期稳定性

Chemical stability of lipid excipients in SLN-production of test formulations, characterisation and short-term stability.

作者信息

Radomska-Soukharev A, Müller R H

机构信息

Dept. of Pharmaceutical Technology, K. Marcinkowski University of Medical Sciences, Poznari, Poland.

出版信息

Pharmazie. 2006 May;61(5):425-30.

PMID:16724540
Abstract

The study investigates the chemical stability of lipids used as excipients in the production of solid lipid nanoparticles (SLN). A total of 17 SLN formulations was produced using different lipids. Most of the formulations were produced using identical binary surfactant mixtures and concentrations to study the effect of the chemical nature of the lipid on its stability in SLN. In some formulations surfactants were exchanged to study the contribution of the surfactant. The particles were characterised by photon correlation spectroscopy, laser diffractometry, zeta potential determination and differential scanning calorimetry, the latter to assess potential effects of lipid crystallinity and modifications on lipid stability. Lipid analysis was performed by gas chromatography using a sampling preparation and analysis procedure especially developed for SLN. This short-term study provides primarily information about the stability of the lipid under production conditions, that means high pressure homogenisation (cavitation) at high temperature. No degradation products couldbe detected for all lipids, the production process itself did not impair excipient stability.

摘要

该研究调查了用作固体脂质纳米粒(SLN)生产辅料的脂质的化学稳定性。使用不同脂质共制备了17种SLN制剂。大多数制剂使用相同的二元表面活性剂混合物和浓度,以研究脂质化学性质对其在SLN中稳定性的影响。在一些制剂中更换了表面活性剂以研究表面活性剂的作用。通过光子相关光谱法、激光衍射法、ζ电位测定和差示扫描量热法对颗粒进行表征,后者用于评估脂质结晶度和修饰对脂质稳定性的潜在影响。脂质分析通过气相色谱法进行,使用专门为SLN开发的采样制备和分析程序。这项短期研究主要提供了关于脂质在生产条件下(即高温高压均质化(空化))稳定性的信息。所有脂质均未检测到降解产物,生产过程本身并未损害辅料的稳定性。

相似文献

1
Chemical stability of lipid excipients in SLN-production of test formulations, characterisation and short-term stability.脂质辅料在测试制剂的SLN生产中的化学稳定性、表征及短期稳定性
Pharmazie. 2006 May;61(5):425-30.
2
Stability of lipid excipients in solid lipid nanoparticles.固体脂质纳米粒中脂质辅料的稳定性
Adv Drug Deliv Rev. 2007 Jul 10;59(6):411-8. doi: 10.1016/j.addr.2007.04.004. Epub 2007 May 3.
3
Solid lipid nanodispersions containing mixed lipid core and a polar heterolipid: characterization.含有混合脂质核心和极性异质脂质的固体脂质纳米分散体:表征
Eur J Pharm Biopharm. 2007 Aug;67(1):48-57. doi: 10.1016/j.ejpb.2006.12.004. Epub 2006 Dec 16.
4
Polyhydroxy surfactants for the formulation of lipid nanoparticles (SLN and NLC): effects on size, physical stability and particle matrix structure.用于脂质纳米粒(固体脂质纳米粒和纳米结晶脂质)制剂的多羟基表面活性剂:对粒径、物理稳定性和粒子基质结构的影响。
Int J Pharm. 2011 Mar 15;406(1-2):163-72. doi: 10.1016/j.ijpharm.2010.12.036. Epub 2011 Jan 8.
5
Investigation of surface-modified solid lipid nanocontainers formulated with a heterolipid-templated homolipid.用杂脂质模板化同脂质制备的表面改性固体脂质纳米容器的研究。
Int J Pharm. 2007 Apr 4;334(1-2):179-89. doi: 10.1016/j.ijpharm.2006.10.032. Epub 2006 Oct 28.
6
Encapsulation of ascorbyl palmitate in nanostructured lipid carriers (NLC)--effects of formulation parameters on physicochemical stability.抗坏血酸棕榈酸酯在纳米结构脂质载体(NLC)中的包封——制剂参数对物理化学稳定性的影响
Int J Pharm. 2007 Aug 1;340(1-2):198-206. doi: 10.1016/j.ijpharm.2007.03.022. Epub 2007 Mar 24.
7
Solid lipid nanoparticles (SLN) for topical drug delivery: incorporation of the lipophilic drugs N,N-diethyl-m-toluamide and vitamin K.用于局部给药的固体脂质纳米粒(SLN):亲脂性药物N,N - 二乙基 - 间甲苯酰胺和维生素K的包封
Pharmazie. 2005 Dec;60(12):905-9.
8
Nanostructured lipid carriers (NLC) on the basis of Siberian pine (Pinus sibirica) seed oil.基于西伯利亚松子油的纳米结构脂质载体(NLC)。
Pharmazie. 2010 Jan;65(1):25-31.
9
Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) -- structural investigations on two different carrier systems.固体脂质纳米粒(SLN)和纳米结构脂质载体(NLC)——两种不同载体系统的结构研究
Biomed Mater Eng. 2005;15(5):393-402.
10
Production & stability of stavudine solid lipid nanoparticles--from lab to industrial scale.司他夫定固体脂质纳米粒的制备及稳定性——从实验室到工业规模。
Int J Pharm. 2011 Sep 20;416(2):461-70. doi: 10.1016/j.ijpharm.2010.08.014. Epub 2010 Aug 18.

引用本文的文献

1
Solidified reverse micellar solution-based chitosan-coated solid lipid nanoparticles as a new approach to enhance oral delivery of artemether in malaria treatment.基于固化反胶束溶液的壳聚糖包被固体脂质纳米粒作为增强蒿甲醚口服给药治疗疟疾的新方法。
BMC Chem. 2025 Mar 8;19(1):64. doi: 10.1186/s13065-025-01422-4.
2
Combined Approach of Cyclodextrin Complexationand Nanostructured Lipid Carriers for the Development of a Pediatric Liquid Oral Dosage Form of Hydrochlorothiazide.环糊精包合与纳米结构脂质载体相结合的方法用于开发氢氯噻嗪儿科液体口服剂型
Pharmaceutics. 2018 Dec 19;10(4):287. doi: 10.3390/pharmaceutics10040287.
3
Design, characterization and in vivo evaluation of nanostructured lipid carriers (NLC) as a new drug delivery system for hydrochlorothiazide oral administration in pediatric therapy.
设计、表征和体内评价纳米结构脂质载体(NLC)作为氢氯噻嗪口服给药的新型药物传递系统在儿科治疗中的应用。
Drug Deliv. 2018 Nov;25(1):1910-1921. doi: 10.1080/10717544.2018.1529209.
4
Rapamycin Loaded Solid Lipid Nanoparticles as a New Tool to Deliver mTOR Inhibitors: Formulation and in Vitro Characterization.负载雷帕霉素的固体脂质纳米粒作为递送mTOR抑制剂的新工具:制剂与体外表征
Nanomaterials (Basel). 2016 May 9;6(5):87. doi: 10.3390/nano6050087.